This research develops a targeted anti-VEGF therapy for wet age-related macular degeneration that can be injected under the skin rather than directly into the eye. In animal studies, the drug successfully reached the eye and reduced abnormal blood vessel growth, offering a safer, cheaper, and more convenient treatment for preventing blindness.

This research teaches AI to understand and generate the sense of touch by combining visual information with high-resolution tactile data. The technology enables realistic digital textures, improves online shopping, enhances virtual experiences, and creates accessible tactile graphics for blind and low-vision users, making AI more inclusive and human-centred.